Endra Life Sciences announced its board of directors has appointed Alexander Tokman as acting CEO to replace Francois Michelon, who stepped down from his role as CEO and as a member of the board of directors to pursue other endeavors. The company also announced the addition to its senior management team of Ziad Rouag as head of regulatory and clinical affairs and Richard Jacroux as CFO.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NDRA: